

QUICK LINKS
Vandetanib inhibits VEGFR-dependent tumor angiogenesis and EGFR- and RET-dependent tumor cell proliferation and survival. Vandetanib is the active ingredient in the drug sold under the trade name Zactima® and is approved for treatment of patients with follicular, medullary, anaplastic, and locally advanced and metastatic papillary thyroid cancer.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Vatalanib Dihydrochloride, 5 mg | sc-202379 | 5 mg | $125.00 | |||
Vatalanib Dihydrochloride, 25 mg | sc-202379A | 25 mg | $374.00 |